trackle GmbH is an innovative MedTech company based in Bonn, Germany, spearheading advancements in fertility management and contraception solutions. Established in 2015, the company has developed the trackle sensor system, a cycle computer that effortlessly enables safe and hormone-free contraception through digital monitoring.
The system's user-friendly approach involves wearing a sensor overnight and syncing data with an app to identify fertile days. With widespread adoption among thousands, trackle provides an effective alternative to traditional contraceptive methods without compromising on safety.
Recognized with certification by TÜV Rheinland as a class IIb medical device manufacturer, trackle underscores its commitment to reliable health solutions. The company recently secured a Venture Round investment in January 2024 from Cross Atlantic Angels, affirming investor confidence and paving the way for further growth in the Health Care and Health and Wellness sectors.